Vancouver, B.C. - TheNewswire - August 24 2020 - Solarvest BioEnergy Inc. ("Solarvest", or the "Company") (TSXV:SVS), is pleased to announced that the Company's German-based contractors have resumed normal operations after a slowdown related to the COVID-19 pandemic. The Company is now advancing toward commercial production of its patented Omega-3 products.
During the slowdown, the Company was able to improve its proprietary process design as well as certify related equipment and further streamline operational logistics.
The Company's patented, chewable, Omega-3 products are organic-certified and algae-based. They are also considered sustainable and suitable for plant-based diets, which contributes to their uniqueness and fills an unmet market need in the essential Omega-3 health products market. Achieving organic certification is a key market differentiator in the growing Omega-3 worldwide market.
The Company's commercial production process will utilize a clean-culture system which ensures the absence of environmental contaminants often found in ocean-based products. The Company will continue to move its proprietary formulation and processes to the German production facilities.
Solarvest BioEnergy Inc. is an algae biotechnology company whose production platform provides it with an extremely flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high value therapeutic protein, recombinant viral antigens (immune stimulating proteins), and Cecropins (antimicrobial peptide/protein). The company has initiated a program for the expression of CBD and THC proteins to be produced in GMP fermentation facilities.
For further information contact:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections.
Copyright (c) 2020 TheNewswire - All rights reserved.